πŸ‡ΊπŸ‡Έ FDA
Patent

US 11795443

Uses of adenosine base editors

granted A61KA61K38/00

Quick answer

US patent 11795443 (Uses of adenosine base editors) held by Beam Therapeutics Inc. expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beam Therapeutics Inc.
Grant date
Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K38/00